# Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

> **NCT07685808** · PHASE2 · RECRUITING · sponsor: **Regeneron Pharmaceuticals** · enrollment: 360 (estimated)

## Conditions studied

- Overweight or Obesity

## Interventions

- **DRUG:** Olatorepatide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07685808
- **Lead sponsor:** Regeneron Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-28
- **Primary completion:** 2028-01-21
- **Final completion:** 2028-01-21
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2026-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07685808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07685808, "Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07685808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*